Fundraising FoxBIO Blast Pharma
New Haven, US · Founded 2012 · Israel corporation
Find your way into BIO Blast Pharma
Sign up to see every warm intro you have to BIO Blast Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BIO Blast Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
PF
Paul FirutaExecutive
RC
Robert CookExecutive
DM
Dalia MegiddoExecutive
WW
Warren WasiewskiExecutive
LC
Leigh CherryExecutive
FP
Fredric PriceExecutive Chairman of the Board2012–2018Fredric Price held executive and board positions at multiple biotech companies including BioBlast Pharma, Chiasma, and BioMarin Pharmaceutical, and previously served as Vice President of Finance at Regeneron Pharmaceuticals and Vice President at Pfizer; he holds a B.A. from Dartmouth College and an M.B.A. from Wharton School of the University of Pennsylvania.
YD
Yaron DanielyExecutive
Board
RN
Ran NusbaumBoard director
MB
Michael BurshtineBoard director
TI
Thomas I. H. DubinBoard director
IK
Isaac KrymolowskiBoard director
Reported raises · per SEC filings
Form D private placements$11.4M disclosed across 2 rounds · 2014–2016
▶$6.7MraisedApr 2016 · 4 investors · PharmaceuticalsRule 506(b)
▶$6.7MraisedApr 2016 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Paul FirutaExecutive Officer
- Theresa M. StevensExecutive Officer
- Robert CookExecutive Officer
- Dalia MegiddoDirector
- Warren WasiewskiExecutive Officer
- Michael BurshtineDirector
- Leigh CherryExecutive Officer
- Fredric PriceExecutive Officer, Director
- Ran NusbaumDirector
- Thomas I. H. DubinDirector
- Isaac KrymolowskiDirector
- Udi GilboaDirector
- Colin FosterExecutive Officer, Director
- Gili CohenDirector
- Marlene HaffnerDirector
- Offering amount
- $6.7M
- Amount sold
- $6.7M
- Sales commissions
- $469K
- Placement agents
- Roth Capital Partners, LLC, H.C. Wainwright & Co., LLC
- First sale
- Mar 2016
- Incorporated
- Corporation, Israel, 2012
- Federal exemptions
- 06b
▶$4.8MraisedFeb 2014 · 28 investors · PharmaceuticalsRule 506(b)
▶$4.8MraisedFeb 2014 · 28 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Marlene HaffnerDirector
- Yaron DanielyDirector
- Dalia MegiddoExecutive Officer, Director
- Udi GilboaExecutive Officer, Director
- Fredric PriceDirector
- Ran NusbaumDirector
- Offering amount
- $4.8M
- Amount sold
- $4.8M
- Minimum investment
- $25K
- Sales commissions
- $332.5K
- Placement agents
- Aegis Capital Corp.
- First sale
- Feb 2014
- Incorporated
- Corporation, Israel, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has BIO Blast Pharma raised?
- BIO Blast Pharma has disclosed $11.4M raised across 2 rounds.
- Where is BIO Blast Pharma headquartered?
- BIO Blast Pharma is headquartered in New Haven, US.